Prognostic marker CD27 and its micro-environmental in multiple myeloma
Abstract Background The Cluster of Differentiation 27 (CD27) is aberrantly expressed in multiple myeloma (MM) -derived. This expression facilitates the interaction between tumor and immune cells within TME via the CD27-CD70 pathway, resulting in immune evasion and subsequent tumor progression. The o...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2024-03-01
|
| Series: | BMC Cancer |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12885-024-11945-z |
| _version_ | 1797247210179526656 |
|---|---|
| author | Xinya Wang Keyang Luo Qiuting Xu Liqun Chi Yiwei Guo Chuiming Jia Lina Quan |
| author_facet | Xinya Wang Keyang Luo Qiuting Xu Liqun Chi Yiwei Guo Chuiming Jia Lina Quan |
| author_sort | Xinya Wang |
| collection | DOAJ |
| description | Abstract Background The Cluster of Differentiation 27 (CD27) is aberrantly expressed in multiple myeloma (MM) -derived. This expression facilitates the interaction between tumor and immune cells within TME via the CD27-CD70 pathway, resulting in immune evasion and subsequent tumor progression. The objective of this study is to investigate the correlation between CD27 expression and the prognosis of MM, and to elucidate its potential relationship with the immune microenvironment. Methods In this research, CD27 expression in T cells within the 82 newly diagnosed MM microenvironment was assessed via flow cytometry. We then examined the association between CD27 expression levels and patient survival. Subsequent a series of bioinformatics and in vitro experiments were conducted to reveal the role of CD27 in MM. Results Clinical evidence suggests that elevated CD27 expression in T cells within the bone marrow serves as a negative prognostic marker for MM survival. Data analysis from the GEO database has demonstrated a strong association between MM-derived CD27 and the immune response, as well as the hematopoietic system. Importantly, patients with elevated levels of CD27 expression were also found to have an increased presence of MDSCs and macrophages in the bone marrow microenvironment. Furthermore, the PERK-ATF4 signaling pathway has been implicated in mediating the effects of CD27 in MM. Conclusions We revealed that CD27 expression levels serve as an indicative marker for the prognosis of MM patients. The CD27- PERK-ATF4 is a promising target for the treatment of MM. |
| first_indexed | 2024-04-24T19:55:04Z |
| format | Article |
| id | doaj.art-87a2dafc52a841e8a5c6c83294274ebf |
| institution | Directory Open Access Journal |
| issn | 1471-2407 |
| language | English |
| last_indexed | 2024-04-24T19:55:04Z |
| publishDate | 2024-03-01 |
| publisher | BMC |
| record_format | Article |
| series | BMC Cancer |
| spelling | doaj.art-87a2dafc52a841e8a5c6c83294274ebf2024-03-24T12:23:26ZengBMCBMC Cancer1471-24072024-03-0124111310.1186/s12885-024-11945-zPrognostic marker CD27 and its micro-environmental in multiple myelomaXinya Wang0Keyang Luo1Qiuting Xu2Liqun Chi3Yiwei Guo4Chuiming Jia5Lina Quan6Hematology Department, Harbin Medical University Cancer HospitalHematology Department, Harbin Medical University Cancer HospitalHematology Department, Harbin Medical University Cancer HospitalHematology Department, Harbin Medical University Cancer HospitalHematology Department, Harbin Medical University Cancer HospitalHematology Department, Harbin Medical University Cancer HospitalHematology Department, Harbin Medical University Cancer HospitalAbstract Background The Cluster of Differentiation 27 (CD27) is aberrantly expressed in multiple myeloma (MM) -derived. This expression facilitates the interaction between tumor and immune cells within TME via the CD27-CD70 pathway, resulting in immune evasion and subsequent tumor progression. The objective of this study is to investigate the correlation between CD27 expression and the prognosis of MM, and to elucidate its potential relationship with the immune microenvironment. Methods In this research, CD27 expression in T cells within the 82 newly diagnosed MM microenvironment was assessed via flow cytometry. We then examined the association between CD27 expression levels and patient survival. Subsequent a series of bioinformatics and in vitro experiments were conducted to reveal the role of CD27 in MM. Results Clinical evidence suggests that elevated CD27 expression in T cells within the bone marrow serves as a negative prognostic marker for MM survival. Data analysis from the GEO database has demonstrated a strong association between MM-derived CD27 and the immune response, as well as the hematopoietic system. Importantly, patients with elevated levels of CD27 expression were also found to have an increased presence of MDSCs and macrophages in the bone marrow microenvironment. Furthermore, the PERK-ATF4 signaling pathway has been implicated in mediating the effects of CD27 in MM. Conclusions We revealed that CD27 expression levels serve as an indicative marker for the prognosis of MM patients. The CD27- PERK-ATF4 is a promising target for the treatment of MM.https://doi.org/10.1186/s12885-024-11945-zCD27Multiple myelomaTumor microenvironmentPrognosisTreatment |
| spellingShingle | Xinya Wang Keyang Luo Qiuting Xu Liqun Chi Yiwei Guo Chuiming Jia Lina Quan Prognostic marker CD27 and its micro-environmental in multiple myeloma BMC Cancer CD27 Multiple myeloma Tumor microenvironment Prognosis Treatment |
| title | Prognostic marker CD27 and its micro-environmental in multiple myeloma |
| title_full | Prognostic marker CD27 and its micro-environmental in multiple myeloma |
| title_fullStr | Prognostic marker CD27 and its micro-environmental in multiple myeloma |
| title_full_unstemmed | Prognostic marker CD27 and its micro-environmental in multiple myeloma |
| title_short | Prognostic marker CD27 and its micro-environmental in multiple myeloma |
| title_sort | prognostic marker cd27 and its micro environmental in multiple myeloma |
| topic | CD27 Multiple myeloma Tumor microenvironment Prognosis Treatment |
| url | https://doi.org/10.1186/s12885-024-11945-z |
| work_keys_str_mv | AT xinyawang prognosticmarkercd27anditsmicroenvironmentalinmultiplemyeloma AT keyangluo prognosticmarkercd27anditsmicroenvironmentalinmultiplemyeloma AT qiutingxu prognosticmarkercd27anditsmicroenvironmentalinmultiplemyeloma AT liqunchi prognosticmarkercd27anditsmicroenvironmentalinmultiplemyeloma AT yiweiguo prognosticmarkercd27anditsmicroenvironmentalinmultiplemyeloma AT chuimingjia prognosticmarkercd27anditsmicroenvironmentalinmultiplemyeloma AT linaquan prognosticmarkercd27anditsmicroenvironmentalinmultiplemyeloma |